Note: Ingredients listed on restricted chemical lists
EC/CAS
265-157-1/64742-54-7
Name of the chemical
Distillates (petroleum), hydrotreated heavy paraffinic
Concentration
49
EC/CAS
224-235-5/4259-15-8
Name of the chemical
Zinc bis[O,O-bis(2-ethylhexyl)] bis(dithiophosphate)
Concentration
0.94 - 1.25
General Information
Version
2.0
Revision date
2024-10-21
Product name
ORLEN OIL MULTI PTF 10W
1.2.1 Relevant identified uses
Professional use,Consumer use
Emergency telephone
48 242010367, +48 242869509, +48242869556
Icons in SDS
Company Information
company name
ORLEN OIL Sp. z o.o
e-mail address of the competent person responsible for the Safety Data Sheet
centrala@orlenoil.pl, msds@orlenoil.pl
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H319
Hazard statements
Code
Statements
H319
Causes serious eye irritation
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
Causes serious eye irritation.
2.2 Label elements
Labelling
Hazard pictograms
GHS07
Signal word
Warning
Hazard statements
H319 - Causes serious eye irritation.
Precautionary statements
P280 - Wear eye protection, protective gloves, protective clothing. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337+P313 - If eye irritation persists: Get medical advice/attention. P501 - Dispose of contents/container to properly labelled waste containers according to the national law.
Supplemental label elements
EUH208 - Contains Benzenesulfonic acid, para-, monoalkylation products with C14-C18 branched olefins (C15 rich) derived from propene oligomerization, calcium salt, overbased including distillates (petroleum), hydrotreated, solvent-refined, solvent-dewaxed, or catalytic dewaxed, light or heavy paraffinic C15-C50 (68610-84-4). May produce an allergic reaction.
2.3 Other hazards
Contains no PBT and/or vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or substance(s) are not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %
